- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03213171
Promoting Organ Donor Registration in Family Physician Offices
Promoting Organ and Tissue Donation Registration in Family Physician Offices: a Pragmatic Stepped-wedge Cluster Randomized Controlled Registry Trial (RegisterNow Trial)
Study Overview
Status
Intervention / Treatment
Detailed Description
Background: There is a worldwide shortage of organs available for transplant, leading to preventable morbidity and mortality. While the majority of the general public in many countries support organ donation, actual donor registration rates are substantially out of step with these views. For instance, in Canada most Canadians support organ donation but less than 25% in most provinces have registered. The family physician office is a promising yet underused setting in which to address known barriers and facilitators to registration for deceased organ and tissue donation and to provide an immediate opportunity to register while in the waiting room for those wanting to do so.
Methods/Design: The investigators aim to evaluate the effects of having reception staff in family physician offices to prompt patients upon check-in with an educational pamphlet using a cluster, stepped-wedge randomized design. A mobile tablet will also be added to the waiting area to provide patients with the immediate opportunity to register. Family physicians are also provided with an educational booklet and encouraged to discuss organ donation with their patients. The investigators will use behaviour change techniques designed to address previously anticipated barriers and enablers to organ and tissue donation registration. The investigators will evaluate the effectiveness of the intervention conducted in six family physician offices in Ontario, Canada. Following a two-week baseline control period, offices will cross sequentially into the intervention arm in a random sequence at two-week intervals until all offices deliver the intervention (baseline + two weeks for each of six offices). The primary outcome will be the proportion of patients that have registered for deceased organ donation following in the 7 days following their office visit, using routinely collected registry data (i.e. administrative databases). The investigators will also conduct a qualitative post-trial process evaluation will assess reception staff and family physicians experiences with the intervention.
Discussion: Promoting organ and donor registration remains an important strategy for organ procurement organizations and patients worldwide. The results of this trial will inform a provincial roll-out strategy to promote organ donation in family physician offices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada
- City of London
-
Stratford, Ontario, Canada
- City of Stratford
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion/Exclusion Criteria for Patients
Inclusion Criteria:
- Patients that visited a family physician
- Patients that are at least 16 years of age with a valid health card (eligibility criteria to register for organ donation in Ontario)
Inclusion/Exclusion Criteria for Family Physicians (Cluster level)
Inclusion Criteria:
- Working at a site that sees at least 100 patients per week
Exclusion Criteria:
- Working at multiple sites that cannot be separated in analyses
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual care
Usual care / Standard of care No intervention implemented
|
|
|
Experimental: Intervention
Reception staff providing handout; Mobile tablet that provides the immediate opportunity for patients to register in the waiting room
|
Reception staff will provide an educational pamphlet to patients that have not yet registered for organ donation
Patients will have the opportunity to immediately register for organ donation using an a mobile tablet (e.g.
IPad)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Donor registration status at 7 days
Time Frame: 7 days
|
Donor registration status (Yes/ Not registered)
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Donor registration status at 14 days
Time Frame: 14 days
|
Donor registration status (Yes/ Not registered)
|
14 days
|
|
Donor registration status at 30 days
Time Frame: 30 days
|
Donor registration status (Yes/ Not registered)
|
30 days
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Li AH, Garg AX, Grimshaw JM, Prakash V, Dunnett AJ, Dixon SN, Taljaard M, Mitchell J, Naylor KL, Faulds C, Bevan R, Getchell L, Knoll G, Kim SJ, Sontrop J, Tong A, Bjerre LM, Hyjek K, Currie D, Edwards S, Sullivan M, Harvey-Rioux L, Presseau J. Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1): a pragmatic stepped-wedge, cluster randomized controlled registry trial. BMC Med. 2022 Mar 3;20(1):75. doi: 10.1186/s12916-022-02266-8.
- Li AH, Garg AX, Prakash V, Grimshaw JM, Taljaard M, Mitchell J, Matti D, Linklater S, Naylor KL, Dixon S, Faulds C, Bevan R, Getchell L, Knoll G, Kim SJ, Sontrop J, Bjerre LM, Tong A, Presseau J. Promoting deceased organ and tissue donation registration in family physician waiting rooms (RegisterNow-1 trial): study protocol for a pragmatic, stepped-wedge, cluster randomized controlled registry. Trials. 2017 Dec 21;18(1):610. doi: 10.1186/s13063-017-2333-5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CIHR-SCT-151609
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Organ Donation
-
University Hospital, Strasbourg, FranceRecruiting
-
Yale-NUS CollegeCompleted
-
Temple UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Royal College of Surgeons, IrelandUniversity of Stirling; Manipal UniversityCompletedOrgan DonationIndia, Ireland, Malaysia, United Kingdom
-
University Hospital, Strasbourg, FranceRecruiting
-
NYU Langone HealthCompletedOrgan DonationUnited States
-
Beth Israel Deaconess Medical CenterCompletedOrgan Donor Registration | Organ Donation EducationUnited States
-
University of ChicagoCompleted
-
Case Western Reserve UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedHealth Behavior | Organ DonationUnited States
-
Nantes University HospitalUniversity of Burgundy; Famirea Study GroupRecruitingOrgan Donation | Intensive Care Units | Required Organ Donation Request | Professional Family RelationsFrance
Clinical Trials on Reception staff providing handout.
-
Emory UniversityCompletedHereditary Breast and Ovarian CancerUnited States